TXT In plain English
Company description
MERCURY PHARMACEUTICALS LIMITED is a UK company whose Companies House status is “Active” and whose registered company type is “Private Limited Company”. Incorporated on 12 June 1991; registered for 35 years; registered office reported in LONDON, UNITED KINGDOM. Its primary declared activity is 21100 · Manufacture of basic pharmaceutical products.
This BritDB profile also contains linked public records: 4 PSC records, 1 trade mark, 7 procurement records. This description is assembled from public data, is not a reliability assessment, and should be checked against the cited sources before a legally significant decision.
Web facts are never added from a name match alone. Internet enrichment requires the exact Companies House ID in Wikidata, and ambiguous results are excluded.
01 Company overview
Identity and registration
- Official name
- MERCURY PHARMACEUTICALS LIMITED
- Company number
- 02619880
- Company type
- Private Limited Company
- Status
- Active
- Country of origin
- United Kingdom
- Dissolution date
- Not supplied
- Accounts category
- FULL
- Mortgage charges
- 15 total · 2 outstanding · 13 satisfied
- Limited partnership members
- 0 general · 0 limited
A registered office is not necessarily a trading location. The address is reproduced from the Companies House bulk record and should be interpreted in that legal context.
02 Filing dates
Accounts and statements
Last accounts made up to
31 December 2025Next accounts due
30 September 2027Last statement made up to
7 July 2026Next statement due
21 July 2027BritDB does not infer overdue status when the source does not state it.
03 Supplier payments
Payment practices and performance
- Reporting period
- 1 January 2026 – 30 June 2026
- Filed
- 23 July 2026
- Shortest standard term
- 45 days
- Longest standard term
- 180 days
- E-invoicing offered
- No
- Supply-chain finance
- Not offered
- Payment codes
- No
- Construction retentions
- No retention clauses reported
Complete reported payment fields
- Policy regime
- Regime-3
- Financial period started
- 1 January 2026
- Qualifying contracts
- Yes
- Payments made
- Yes
- Invoice value paid within 30 days
- £33,898,684
- Invoice value paid in 31–60 days
- £3,168,309
- Invoice value paid after 60 days
- £1,606,250
- Invoice value paid outside agreed terms
- £10,119,630
- Invoices paid in 31–60 days
- 1.0%
- Invoices unpaid due to dispute
- 0.0%
- Maximum contractual payment period
- 180 days
- Supplier-list charging policy
- No
- Supplier-list charges made
- No
Maximum contractual payment information
We have maximum 180 days contractual payment period for intercompany vendors and 45 days for external vendors.
- Retention in all contracts
- No
- Retention in standard terms
- No
- Retention threshold
- Not supplied
- Standard retention rate
- Not supplied
- Retention compared with client
- Not supplied
- Retention compared with payments
- Not supplied
Reported terms and dispute process
- Standard payment terms
The Company follows a standard payment terms of "30 days end of the following month, in which the invoice is received". For Intercompany Vendor's the standard terms are "180 days from the date of invoice"
The maximum contractual payment period (in days) - The maximum contractual payment terms for Intercompany Vendors is "180 days from the date of Invoice", for Vendors other than Intercompany vendors, the maximum contractual term is "30 days end of the following month"
There have been no changes to the company standard terms during the reporting period. - Other payment-term information
Average pay days for external vendors is 41 days (Excluding inter company vendors)
- Dispute resolution process
a) In case of any invoice disputes, the relevant department within the company availing the services is informed by email. The relevant department would then inform the vendor via email/phone of the nature of dispute and get it resolved. b) In case of disputes relating to services, the relevant department before approving the costs would inform the Vendor over an email. In case the invoice is considered to be correct, the same is internally approved and paid. c)For minor invoice errors, the Finance department may send an email directly to the relevant finance contact on Vendor side.
Earlier payment reports (11 shown)
- 1.0 average days to pay2.0% outside terms
- 0.0 average days to pay2.0% outside terms
- 12.0 average days to pay3.0% outside terms
- 21.0 average days to pay9.0% outside terms
- 29.0 average days to pay19.0% outside terms
- 78.0 average days to pay9.0% outside terms
- 76.0 average days to pay10.0% outside terms
- 78.0 average days to pay11.0% outside terms
- 29.0 average days to pay13.0% outside terms
- 9.0 average days to pay8.0% outside terms
- 29.0 average days to pay13.0% outside terms
This is a company-submitted statutory disclosure, not a credit rating. BritDB preserves the reporting period and links the report only through the Companies House number supplied by the official service. Percentages describe payments made during that period and may change in later reports.
04 Supply-chain transparency
Modern slavery statement
- Organisation
- MERCURY PHARMACEUTICALS LIMITED
- Group submission
- Yes
- Parent organisation
- ADVANZ PHARMA SERVICES (UK) LIMITED
- Statement period
- 1 January 2020 – 31 December 2020
- Approved
- 14 May 2021
- Sectors
- Healthcare and pharmaceuticals
Organisation structure
Covered in the statement
Policies
Covered in the statement
Risk assessment
Covered in the statement
Due diligence
Covered in the statement
Training
Covered in the statement
Goals and KPIs
Covered in the statement
Full statement information supplied to the registry
- Reported turnover band
- £100 million to £500 million
- Years producing statements
- 1 to 5 years
- ILO indicators included
- Not answered
- Registry record updated
- 28 July 2021
Policies described
Freedom of workers to terminate employment Prohibits any threat of violence, harassment and intimidation Prohibits child labour Prohibits discrimination
Training described
Your whole organisation
Worker engagement and working conditions
Your suppliers Professional auditors Workers within your organisation Workers within your supply chain
Grievance mechanisms
Using anonymous whistleblowing services, such as a helpline or mobile phone app
Other monitoring
We have a contractual right to visit the facilities of our Suppliers and Manufacturers to control the way they operate (including the working conditions across their operations).
Demonstrated progress
We take a range of measures to monitor the effectiveness of the steps that we are taking to ensure that slavery and/or human trafficking is not taking place within our business or Partners. We are committed to continuously improving the way we manages our business operations. As part of this commitment we will continue to review and improve our policies, processes and controls to ensure that modern slavery does not take place in any of our supply chains or our own business.
Reported risks and mitigations
- Risk: Global business activities in multiple locations and jurisdictions with various approaches regarding modern slavery.
- Area: Within your supply chains
- Tier: Tier 1 suppliers Tier 2 suppliers Tier 3 suppliers and below
- Group: Migrants Refugees Children
- Location: India
- Mitigation: ADVANZ PHARMA has implemented a “Standards for Product Manufacturers and Suppliers” Policy that sets forth ADVANZ PHARMA standards and requirements for all its Manufacturers and Suppliers in the areas of ethics, labor rights, health and safety, environmental and human rights practices. In addition we require from any new business partner to complete and sign an Anti-Corruption and Modern Slavery Declaration and to comply with all the mentioned requirements.
- Risk: Business interactions with a large scale of third party vendors, including distributors, suppliers, manufacturers which means that compliance with applicable Human rights laws is harder to control.
- Risk: Operational entities in several locations and jurisdictions with a decentralised management structure which increases the difficulty to monitor and control staff behaviour.
- Area: Within your own operations
- Group: Migrants Children
- Mitigation: We have implemented a robust Compliance programme within the Group including policies, control processes and trainings, In addition we are conducting internal and external audits on a yearly basis to control and monitor our worlwide activities.
A registry entry records what the organisation declared in its statement. It is not an independent audit. Group statements can cover several companies; BritDB preserves each exact source-supplied company-number link and excludes approver names and email addresses.
05 Data protection
ICO fee-payer registration
Mercury Pharmaceuticals Limited
Registration Z4972615
- Registered from
- 23 August 2000
- Current end date
- 22 August 2027
- Trading names
- HEALTHY DIGEST, GOLDSHIELD PHARMACEUTICALS, GOLDSHIELD HEALTHCARE, PROFESSIONAL CARE
This is a candidate association, not an official Companies House link. The ICO file supplies no company number. The organisation name and postcode uniquely matched this company in the current snapshot. BritDB excludes all DPO contact fields and does not publish unmatched personal entries.
06 Public procurement
Contracts Finder awards
NHS Framework Agreement for Branded Medicines - National
NHS England · ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7
- Supplier named in award
- Mercury Pharmaceuticals Limited
- Award value
- £1,351,341,890
- Contract period
- 1 May 2019 – 30 April 2021
- Published
- 9 August 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7-2019-08-09T15:57:38+01:00
The supplier link is exact, but the award remains buyer-published procurement data. BritDB requires the GB-COH identifier supplied in the Contracts Finder OCDS release and does not infer suppliers from similar names.
TM UK trade marks
Exact owner-name matches
This is an exact normalised company-name match, not a registrar-confirmed ownership link. Another legal entity can have the same or a very similar name. UKIPO data is a historical 2018 snapshot; verify the owner and current status before relying on it.
07 Ownership and control
People with significant control
Mercury Pharma Group Limited
- Owns 75% or more of shares
- Controls 75% or more of voting rights
- Can appoint or remove directors
- Country registered
- United Kingdom
- Legal authority
- Companies Act 2006
- Legal form
- Private Limited Company
- Place registered
- Companies House
- Registration number
- 02330913
- Notified
- 1 June 2021
The Blackstone Group Inc.
- Owns 25% to 50% of shares
- Controls 25% to 50% of voting rights
- Country registered
- Delaware
- Legal authority
- Delaware
- Legal form
- Corporation
- Place registered
- Delaware Secretary Of State
- Registration number
- 4315990
- Notified
- 27 March 2020
- Ceased
- 1 June 2021
Mercury Pharma Group Limited
- Owns 75% or more of shares
- Controls 75% or more of voting rights
- Can appoint or remove directors
- Country registered
- United Kingdom
- Legal authority
- England And Wales
- Legal form
- Private Limited Company
- Place registered
- Uk Companies House
- Registration number
- 02330913
- Notified
- 10 August 2018
- Ceased
- 27 March 2020
No individual or entity with signficant control
- Notified
- 7 July 2016
- Ceased
- 10 August 2018
PSC records are company-filed public-register information. When the exact same displayed individual name occurs at multiple companies, BritDB offers a non-indexed cross-reference page. It is a name match only, not proof that the records describe the same person. Service addresses and partial dates of birth are deliberately omitted.
08 Charity register
Charity Commission links
No exact company-number link in this snapshot
The Charity Commission extract did not explicitly associate this Companies House number with a charity. BritDB does not use a name-only match to fill the gap.
This company-level check covers the Charity Commission for England and Wales. Links are accepted only when the official extract supplies this exact company registration number. Scottish charities now have separate OSCR profiles, but OSCR’s bulk fields do not provide a Companies House number, so BritDB does not infer a company link.
09 Northern Ireland charity register
CCNI exact company links
No unambiguous company-number link found
The CCNI source number did not resolve uniquely to this Companies House record. BritDB did not use a name or address match.
CCNI publishes company numbers without a jurisdiction prefix. BritDB links only when the plausible padded UK and NI candidates resolve to exactly one Companies House company.
10 Sanctions screening
UK Sanctions List
No exact business-registration-number link found
The imported UK Sanctions List did not supply this Companies House number as a UK-linked business identifier. BritDB did not attempt a name-only match.
No exact link is not sanctions clearance. UK restrictions can apply through ownership or control even where an entity is not separately named. Always use the current official list and obtain appropriate advice for a legally significant decision.
11 Public procurement
Find a Tender links
Generic, Branded Generic & Proprietary Medicinal Products - Group 18
Regional Business Services Organisation, Procurement and Logistics Service · updated 3 July 2026
- Tender value
- £1,800,000,000
- Awards
- 214
NHS National Framework Agreement for Omalizumab
NHS England · updated 30 December 2025
- Tender value
- £85,785,000
- Awards
- 2
NHS National Framework for Generics Housekeeping
NHS England · updated 22 December 2025
- Tender value
- £52,023,284
- Awards
- 2
NHS National Framework for Golimumab Injection
NHS England · updated 17 October 2025
- Tender value
- £107,912,000
- Awards
- 2
NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
NHS England · updated 24 April 2026
- Tender value
- £115,756,000
- Awards
- 2
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS England · updated 6 October 2025
- Tender value
- £1,520,432,295
- Awards
- 3
These links use only the GB-COH identifier supplied in the procurement record. A company may have other public-sector work that is absent, older, below publication thresholds or published without a Companies House identifier.
12 Environmental register
Environment Agency waste registrations
No exact company-number registration linked
The licensed Environment Agency subset did not contain this exact Companies House number. BritDB did not attempt a name-only match.
This is a privacy-reduced, exact-company subset. The full official register also includes sole traders and applicants without a matching Companies House number. Check the current Environment Agency register before relying on registration status.
13 Nature of business
Standard Industrial Classification
14 Connected public record
Checks beyond the company register
Charity Commission
0 exact company-number links.
Northern Ireland charities
0 unambiguous company-number links.
Public contracts
6 procurement processes linked by exact GB-COH identifier.
Waste register
0 exact company-number registrations.
Corporate notices
The Gazette is not yet connected.
UK Sanctions List
No exact business-registration-number link in this report.
A checked source with no exact link is not a clean bill of health. Unchecked sources remain unknown, while sanctions may also apply through ownership or control of a listed person or entity.
15 Record timeline
Dates in the bulk record
- Detected change
Accounts due date: 2026-09-30 → 2027-09-30
- Confirmation statement
Latest confirmation statement made up to this date
- Accounts
Latest accounts made up to this date
- Company name
Previous name: MERCURY PHARMA LIMITED
- Company name
Previous name: GOLDSHIELD PHARMACEUTICALS LTD.
- Incorporation
Company incorporated
16 Provenance
Sources for this profile
Identity, address, status, dates, SIC, previous names and mortgage totals.
Statutory supplier-payment reports linked by the exact source-supplied Companies House number.
Annual statement summaries linked by exact source company number.
Privacy-reduced candidate associations based on a unique exact name-and-postcode match.
Historic awards linked by exact source-supplied GB-COH company identifier.
Current and ceased significant-control records joined by exact company number.
Daily England and Wales extract matched only by the official company registration number.
Daily CCNI export with company links only where the source number resolves unambiguously.
Complete FCDO list checked by exact UK-linked business registration number.
Procurement parties checked only through exact GB-COH identifiers.
Licensed subset linked only by exact Companies House number.
Financial regulation and licences.
Companies House, Charity Commission, OSCR and UK Sanctions List information is public-register data. BritDB reproduces and organises it with source-specific limits; official external links are kept on the dedicated source pages.